Mcpherson'S Ltd

Consumer Defensive AU MCP

0.305AUD
-(-%)

Last update at 2024-12-24T01:49:00Z

Day Range

0.300.30
LowHigh

52 Week Range

0.300.64
LowHigh

Fundamentals

  • Previous Close 0.30
  • Market Cap45.34M
  • Volume24999
  • P/E Ratio-
  • Dividend Yield11.94%
  • EBITDA-5.74700M
  • Revenue TTM144.65M
  • Revenue Per Share TTM1.00
  • Gross Profit TTM 103.13M
  • Diluted EPS TTM-0.08

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -4.67200M 0.44M -4.46200M 13.26M 18.98M
Minority interest - - - - -
Net income -5.06100M 0.33M -5.04100M 6.06M 13.72M
Selling general administrative 39.32M 39.60M 38.48M 35.60M 35.95M
Selling and marketing expenses 32.25M 29.18M 26.95M 25.97M 28.86M
Gross profit 103.07M 90.80M 87.48M 106.08M 99.11M
Reconciled depreciation 5.99M 5.67M 5.08M 4.90M 2.13M
Ebit 8.58M 1.61M 1.74M 23.23M 20.11M
Ebitda 14.56M 7.29M 6.82M 28.13M 22.24M
Depreciation and amortization 5.99M 5.67M 5.08M 4.90M 2.13M
Non operating income net other - - - - -
Operating income 8.55M 1.03M 3.05M 27.03M 20.11M
Other operating expenses 0.96M 33.71M 21.41M 24.02M 189.81M
Interest expense 1.79M 1.18M 1.20M 1.46M 0.96M
Tax provision 0.39M 0.10M 0.58M 7.20M 5.26M
Interest income 0.02M 0.03M 0.01M 4.98M 1.34M
Net interest income -1.76200M -1.14400M -1.18700M -1.45500M -0.88600M
Extraordinary items - - - - 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.39M 0.10M 0.58M 7.20M 5.26M
Total revenue 210.26M 214.00M 200.50M 222.19M 210.34M
Total operating expenses 94.58M 89.92M 84.23M 79.61M 78.59M
Cost of revenue 107.19M 123.20M 113.02M 116.11M 111.23M
Total other income expense net -11.40200M 0.70M -6.51800M -12.04700M -1.13400M
Discontinued operations - - - - -
Net income from continuing ops -5.06100M 0.33M -5.04100M 6.06M 13.72M
Net income applicable to common shares -5.06100M 0.33M -5.04100M 6.06M 13.72M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 146.90M 187.20M 212.03M 195.00M 186.80M
Intangible assets - 45.09M 56.82M 56.99M 48.96M
Earning assets - - - - -
Other current assets 0.82M 0.99M 0.85M 1.10M 0.00000M
Total liab 57.26M 77.75M 91.23M 80.04M 96.57M
Total stockholder equity 89.64M 109.45M 120.81M 114.95M 90.23M
Deferred long term liab - - - - -
Other current liab 13.26M 33.83M 45.27M 35.55M 37.09M
Common stock 217.22M 217.22M 207.24M 206.36M 159.44M
Capital stock - 217.22M 207.24M 206.36M 159.44M
Retained earnings -126.10900M -105.80000M -94.98100M -90.60600M -73.55700M
Other liab - 9.73M 10.68M 9.06M 9.23M
Good will 23.73M 33.73M 33.64M 33.55M 15.76M
Other assets - 7.59M 9.12M 0.28M 1.95M
Cash 24.77M 7.03M 13.14M 7.35M 7.15M
Cash and equivalents - - - - -
Total current liabilities 46.73M 47.23M 69.62M 54.40M 67.14M
Current deferred revenue 12.37M -4.66300M -18.45800M -4.36000M -4.50700M
Net debt -5.13200M 18.42M 16.24M 13.57M 17.52M
Short term debt 14.07M 4.66M 18.46M 4.36M 4.51M
Short long term debt - 0.93M 14.89M - -
Short long term debt total 19.64M 25.45M 29.38M 20.93M 24.67M
Other stockholder equity - -111.41800M -112.26300M -115.42700M -85.88700M
Property plant equipment - 18.11M 19.68M 9.89M 11.29M
Total current assets 75.78M 82.68M 92.77M 94.17M 100.93M
Long term investments - - - 0.11M 1.91M
Net tangible assets - 30.64M 30.34M 24.41M 25.52M
Short term investments - - 0.36M - 6.00M
Net receivables 24.53M 28.89M 29.76M 37.62M 46.70M
Long term debt - 12.59M 0.00000M 15.77M 16.38M
Inventory 25.66M 45.16M 45.54M 48.10M 47.09M
Accounts payable 7.03M 13.39M 24.35M 18.84M 30.04M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -1.47200M -1.96600M 8.54M -0.80300M 4.34M
Additional paid in capital - - - - -
Common stock total equity - - - - 159.44M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 32.92M 7.59M 8.85M - 7.76M
Deferred long term asset charges - - - - -
Non current assets total 71.12M 104.52M 119.27M 100.82M 85.87M
Capital lease obligations - 11.93M 14.49M 5.16M 8.29M
Long term debt total - 20.79M 10.92M 16.57M 20.16M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -1.84900M -2.25500M -31.80100M -3.63000M -1.15800M
Change to liabilities -9.24800M 1.56M -8.26700M 17.93M 4.23M
Total cashflows from investing activities -1.84900M -2.25500M -31.80100M -8.14400M -10.44900M
Net borrowings -5.15000M -4.80200M -4.84300M -5.32600M -0.51800M
Total cash from financing activities -10.91000M -10.59400M 29.42M -14.50800M -7.57600M
Change to operating activities -0.49000M 0.25M -1.20200M 1.83M -1.00700M
Net income -5.06100M 0.33M -5.37100M 6.06M 13.72M
Change in cash -6.10800M 5.79M 0.20M -3.32300M 1.86M
Begin period cash flow 13.14M 7.35M 7.15M 10.47M 8.61M
End period cash flow 7.03M 13.14M 7.35M 7.15M 10.47M
Total cash from operating activities 6.55M 18.57M 2.69M 19.33M 19.78M
Issuance of capital stock - - 45.91M - -
Depreciation 5.99M 5.67M 5.55M 4.90M 2.13M
Other cashflows from investing activities - - -0.85600M -2.69800M -4.52900M
Dividends paid -5.75800M -5.78900M -10.30300M -9.15900M 7.05M
Change to inventory 0.43M 2.49M 2.30M -10.35300M 1.39M
Change to account receivables 0.77M 7.83M 10.94M -15.52100M -1.05700M
Sale purchase of stock -0.00200M -0.00300M -1.34900M -0.02300M -0.01000M
Other cashflows from financing activities -3.78300M -3.91800M 91.33M -3.76700M 62.98M
Change to netincome 12.47M 0.54M 5.42M 13.29M 0.17M
Capital expenditures 1.85M 2.25M 2.53M 1.82M 4.76M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.20M 10.32M 13.24M -25.87400M 0.03M
Stock based compensation -0.10400M 0.38M 1.50M 0.67M -
Other non cash items 5.62M 12.57M 2.51M 8.37M -15.84900M
Free cash flow 4.70M 16.32M 0.17M 17.52M 15.02M

Peer Comparison

Sector: Consumer Defensive Industry: Household & Personal Products

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MCP
Mcpherson'S Ltd
- -% 0.30 - 16.08 0.31 0.54 0.30 16.32
S66
Star Combo Pharma Ltd
- -% 0.14 13.00 - 0.67 0.57 0.60 5.59
PTL
Prestal Holdings Limited
- -% 0.09 - - 0.69 0.54 0.52 5.04
ZNO
Zoono Group Ltd
- -% 0.03 - - 8.81 1.48 8.51 -1.3808
AN1
Anagenics Ltd
- -% 0.008 - - 0.34 1.36 0.26 -3.9793

Reports Covered

Stock Research & News

Profile

McPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. The company offers beauty care, hair care, skin care, and personal care items, including facial wipes, cotton pads, and foot comfort products; and vitamins and supplements, as well as fragrance and nutrition. It sells its products primarily under the brands, including Dr. LeWinn's, A'kin, Manicare, Lady Jayne, Swisspers, Fusion Health, Oriental Botanicals, Maseur, Glam by Manicare, Revitanail, Footcare by Maseur, and Stratton. The company was founded in 1860 and is headquartered in Kingsgrove, Australia.

Mcpherson'S Ltd

105 Vanessa Street, Kingsgrove, NSW, Australia, 2208

Key Executives

Name Title Year Born
Mr. Grant W. Peck C.A. MD, CEO & Director NA
Mr. Paul Witheridge B.Com, B.Com., C.A., CA CFO & Joint Company Sec. NA
Ms. Lori Pirozzi National Accounts Director NA
Donna Chan Marketing Director NA
Ms. Lisa Sheehan Chief People Officer NA
Mr. Philip R. Bennett BCom, CA Joint Company Sec. NA
Mr. Sammy K. S. Chan Managing Director of McPherson's Hong Kong Limited NA
David Fielding Director of Strategy, Planning and Innovation NA
Mary Pearce R&D Director NA
Dawn Swainston Gen. Mang. of Health NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.